News - Noven Pharmaceuticals


Current filters:

Noven Pharmaceuticals

Popular Filters

Noven's Brisdelle is first non-hormonal treatment for menopausal hot flashes to be approved by FDA


The US Food and Drug Administration on Friday (June 28) approved Noven Pharmaceuticals' Brisdelle (paroxetine)…

BrisdelleHisamitsu PharmaNorth AmericaNoven PharmaceuticalsparoxetinePharmaceuticalRegulationWomen's Health

US FDA warns pregnant women to not use valproate migraine prevention medicines


The US Food and Drug Administration is alerting health care providers and patients that medications including…

Abbott LaboratoriesGenericsNeurologicalNorth AmericaNoven PharmaceuticalsPharmaceuticalRegulationSanofivalproate Sodium Injection

Noven files NDA for non-hormonal therapy for menopausal vasomotor symptoms


USA-based Noven Pharmaceuticals, a wholly-owned subsidiary of Japanese drugmaker Hisamitsu Pharmaceuticals…

Hisamitsu PharmaNorth AmericaNoven PharmaceuticalsPharmaceuticalRegulationWomen's Health

Back to top